This assertion would be consistent with the father’s negative history of recurrent respiratory or other infection; however, given the variable expressivity of the infection phenotype, additional studies are needed to determine whether increased IRAK1 dosage is necessary and/or sufficient to manifest recurrent infections in MECP2 duplication patients. Here, MECP2 is linked to infection.